Biomaterials are artificially derived natural materials that are used in medical applications such as organ transplantation and replacement of tissues. The global market for medical devices was accounted to $240 billion in 2013. This shows the potential for growth of biomaterial market. Increase in aging population is the major driver for biomaterial market. Due to the increase in number of aging patients, the usage of biomaterial in wound healing, plastic surgery, neurology and tissue engineering is increasing. According to the Society for Biomaterials, there are more than 5000 novel research article published every year for improved wound care techniques and surgical devices. Biomaterials market growth is hindered by certain factors such as inflammatory responses and strict government regulations for commercialization. In 1999, Government of Norway conducted “Dental Biomaterial- Adverse Reaction Unit” activity to control and evaluate adverse implication in dental fields.
The global biomaterial market is challenged by above restraints; however, companies are developing novel techniques to overcome these challenges. Companies are collaborating to build extra competitive advantage in biomaterial market. For Example, Wright Medical Group recently acquired BioMimetic Therapeutics Inc. to explore opportunities for Wright’s Extermities business. This report provides key strategies adopted by top players engaged in this business. The report provides regulatory intelligence for biomaterial according to geographies.
Key companies included in the report are Morgan Tecxhnical Ceramics, BASF SE, Collagen Matrix Inc., Wright Medical Group Inc., Bayer AG, Kyocera Corporation, Cam Bioceramics BV, Ticona Gmbh, Noble Biomaterials Inc., and Biomet Inc
Key developmental strategies adopted by top market players engaged in this business to provide better understanding of potential opportunities and challenges in this market
Market estimation of applications, types of materials and geographic segment is derived from current market scenario and expected market trends
The report provides an in-depth understanding of the market scenarios in various geographic regions so that key players can make plans to explore opportunities in specific regions
In depth analysis of key drivers, restraints and opportunities of biomaterials market with impact analysis
Value chain analysis, Porter’s five forces model, top investment pockets (GE9 Cell Matrix) are analyzed and presented in detail in the report
KEY MARKET SEGMENTSBY TYPE OF MATERIAL
Medical device manufacturing companies
Let us know more about your research need and we will customize an offer exclusively for you!
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR)
encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only
engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates
and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within
each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors
and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis
and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and
allow stakeholders to make informed decisions.
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to:
Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
High prevalence of chronic diseases and growing healthcare awareness has boosted the market growth for neuroprosthetic devices/implants. This research report provides pin-point analysis of the global neuroprosthetics market, including market estimates and trends through 2020. The report contains an in-depth analysis of different segments such as neuroprosthetics technologies, types, applications and geography.
Capsule endoscopy is a non-invasive technique that allows the complete examination of the gastrointestinal tract using a wireless, disposable device known as a video capsule, which is equipped with a camera, battery, transmitter and a light source.battery, transmitter and a light source. Video capsules capture images in the esophagus, stomach and small intestine, which are utilized for the diagnosis of gastrointestinal diseases.
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market.
In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.
Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices, which has increased the adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps that are bridged by the innovative CGM.
Vertebral Compression Fracture (VCF) is a medical condition that occur due to the fractures, cracks and collapses in the bone of spinal column. Vertebral compression fractures are most often caused by osteoporosis, which accounts for ~85% of all VCF cases. It can also occur due to trauma, multiple myeloma, metastasis and malignant bone tumors that may cause spine collapse.
Meningococcal vaccines are used to treat meningitis caused by bacterium N. meningitidis. Previously there were no precautionary measures available to avoid meningitis. Antibiotics along with nutrient supplements were used to treat this disease after infection was confirmed. However, with the advent of meningococcal vaccine, meningitis could be prevented. The global market for vaccines was estimated to be $24 billion in 2013.
Cardiovascular surgery is the process performed to cure the heart tissue defects such as replacing the diseased heart valves if it is blocked, grafting or replacement of heart tissues in case of damage. There are two major types of heart surgeries performed, namely closed and open types of surgeries. The global surgical device market is the parent market for cardiovascular devices, which was valued at $240 billion in 2013.